Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Neuroectodermal Tumors × Aminolevulinic Acid × Clear all

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Glioma 3 Brain Neoplasms 2 Pituitary Neoplasms 1 Neuroectodermal Tumors 1 Neoplasms, Neuroepithelial 1 Neoplasms 1 Neoplasm, Residual 1 Keratosis, Actinic 1 Central Nervous System Neoplasms 1

Interventions

lutetium Lu 177 dotatate 1 copper dotatate CU-64 1 Lutetium-177 1 Lutetium 1 Aminolevulinic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05850377 2023-05-09

5-Aminolevulinic Acid (5-ALA) Gliolan®: Usage Increase Proposal for Neurosurgical Procedures in High-Grade Gliomas

Sociedad de Lucha Contra el Cáncer del Ecuador

Not yet recruiting

Brain Neoplasms, Glioma, Neoplasms, Central Nervous System Neoplasms, Neuroectodermal Tumors, Neoplasms, Neuroepithelial, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon ⚡